Patient Guide: Phase III A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis (BREEZE-AD-PEDS)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTBREEZE-AD-PEDS
Status: COMPLETED
Condition: Atopic Dermatitis
Phase: PHASE3

Loading interactive enrollment tools...

The full interactive experience will load momentarily